|
1
|
Bang YJ, Van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER2-positive advanced gastric
or gastro-oesophageal junction cancer (ToGA): A phase 3,
open-label, randomised controlled trial. Lancet. 376:687–697. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim SS, Ruiz VE, Carroll JD and Moss SF:
Helicobacter pylori in the pathogenesis of gastric cancer and
gastric lymphoma. Cancer Lett. 305:228–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Correa P and Piazuelo MB: Helicobacter
pylori infection and gastric adenocarcinoma. US Gastroenterol
Hepatol Rev. 7:59–64. 2011.PubMed/NCBI
|
|
4
|
Testerman TL and Morris J: Beyond the
stomach: An updated view of Helicobacter pylori pathogenesis,
diagnosis, and treatment. World J Gastroenterol. 20:12781–12808.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mbulaiteye SM, Hisada M and El-Omar EM:
Helicobacter pylori associated global gastric cancer burden. Front
Biosci (Landmark Ed). 14:1490–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Herrera V and Parsonnet J: Helicobacter
pylori and gastric adenocarcinoma. Clin Microbiol Infect.
15:971–976. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brawner KM, Morrow CD and Smith PD:
Gastric microbiome and gastric cancer. Cancer J. 20:211–216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Atherton JC, Cao P, Peek RM Jr, Tummuru
MK, Blaser MJ and Cover TL: Mosaicism in vacuolating cytotoxin
alleles of Helicobacter pylori. Association of specific vacA types
with cytotoxin production and peptic ulceration. J Biol Chem.
270:17771–17777. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ziel KA, Campbell CC, Wilson GL and
Gillespie MN: Ref-1/Ape is critical for formation of the
hypoxia-inducible transcriptional complex on the hypoxic response
element of the rat pulmonary artery endothelial cell VEGF gene.
FASEB J. 18:986–988. 2004.PubMed/NCBI
|
|
10
|
Harris PR, Smythies LE, Smith PD and
Perez-Perez GI: Role of childhood infection in the sequelae of H.
pylori disease. Gut Microbes. 4:426–438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee WP, Tai DI, Lan KH, Li AF, Hsu HC, Lin
EJ, Lin YP, Sheu ML, Li CP, Chang FY, et al: The −251T allele of
the interleukin-8 promoter is associated with increased risk of
gastric carcinoma featuring diffuse-type histopathology in Chinese
population. Clin Cancer Res. 11:6431–6441. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shikata K, Kiyohara Y, Kubo M, Yonemoto K,
Ninomiya T, Shirota T, Tanizaki Y, Doi Y, Tanaka K, Oishi Y, et al:
A prospective study of dietary salt intake and gastric cancer
incidence in a defined Japanese population: The Hisayama study. Int
J Cancer. 119:196–201. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Correa P, Fontham ET, Bravo JC, Bravo LE,
Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD and Mera
R: Chemoprevention of gastric dysplasia: Randomized trial of
antioxidant supplements and anti-Helicobacter pylori therapy. J
Natl Cancer Inst. 92:1881–1888. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan AO, Chu KM, Yuen ST, Leung SY, Lam SK
and Wong J: Synchronous gastric adenocarcinoma and
mucosa-associated lymphoid tissue lymphoma in association with
Helicobacter pylori infection: Comparing reported cases between the
East and West. Am J Gastroenterol. 96:1922–1924. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Sanjose S, Dickie A, Alvaro T, Romagosa
V, Villanueva M Garcia, Domingo-Domenech E, de Sevilla A Fernandez
and El-Omar E: Helicobacter pylori and malignant lymphoma in Spain.
Cancer Epidemiol Biomarkers Prev. 13:944–948. 2004.PubMed/NCBI
|
|
16
|
Parsonnet J, Hansen S, Rodriguez L, Gelb
AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH and Friedman GD:
Helicobacter pylori infection and gastric lymphoma. N Engl J Med.
330:1267–1271. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hussell T, Isaacson PG, Crabtree JE, Dogan
A and Spencer J: Immunoglobulin specificity of low grade B cell
gastrointestinal lymphoma of mucosa-associated lymphoid tissue
(MALT) type. Am J Pathol. 142:285–292. 1993.PubMed/NCBI
|
|
18
|
Wotherspoon AC, Doglioni C, Diss TC, Pan
L, Moschini A, de Boni M and Isaacson PG: Regression of primary
low-grade B-cell gastric lymphoma of mucosa-associated lymphoid
tissue type after eradication of Helicobacter pylori. Lancet.
342:575–577. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cavanna L, Pagani R, Seghini P, Zangrandi
A and Paties C: High grade B-cell gastric lymphoma with complete
pathologic remission after eradication of Helicobacter pylori
infection: Report of a case and review of the literature. World J
Surg Oncol. 6:352008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu H, Ye H, Ruskone-Fourmestraux A, De
Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch
T, et al: T(11;18) is a marker for all stage gastric MALT lymphomas
that will not respond to H. pylori eradication. Gastroenterology.
122:1286–1294. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fukayama M and Ushiku T: Epstein-Barr
virus-associated gastric carcinoma. Pathol Res Pract. 207:529–537.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park S, Lee J, Ko YH, Han A, Jun HJ, Lee
SC, Hwang IG, Park YH, Ahn JS, Jung CW, et al: The impact of
Epstein-Barr virus status on clinical outcome in diffuse large
B-cell lymphoma. Blood. 110:972–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Engels EA, Cho ER and Jee SH: Hepatitis B
virus infection and risk of non-Hodgkin lymphoma in South Korea: A
cohort study. Lancet Oncol. 11:827–834. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yood M Ulcickas, Quesenberry CP Jr, Guo D,
Caldwell C, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U and
Manos MM: Incidence of non-Hodgkin's lymphoma among individuals
with chronic hepatitis B virus infection. Hepatology. 46:107–112.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
NCCN, . National Comprehensive Cancer
Network Guidelines for gastric cancer. Version 3. 2016.https://www.nccn.org/professionals/physician_gls/f_guidelines.aspAccessed
September 12, 2016.
|
